Neovasc Inc (NVCN)

[Ryoko]

It seems the RS is because they want to stay listed on NASDQ, where they presumably would have an easier time issuing new shares. (Shares priced in the dollar range on NASDQ look far more attractive than sub-penny crap on OTC.) They will have to continue diluting to keep the lights on until they receive FDA approval which is going to take a while. With that in mind, the price is going down barring some significant news of progress (pending approval, for example) or some sort of buyout offer.